Drug moisture-proof packaging refers to packaging with moisture-proof function, which is mainly used in solid drugs such as tablets and capsules. Paxlovid (Paxlovid) is Pfizer's new coronavirus treatment drug, its dosage form is tablet, and this packaging is also selected.
75ml child resistant bottle
Paxlovid (Paxlovid) is an oral small-molecule novel coronavirus therapy drug for the treatment of adults with mild to moderate novel coronavirus pneumonia (COVID-19) patients with high risk factors for progression to severe disease, such as those with advanced age, Patients with severe high-risk factors such as chronic kidney disease, diabetes, cardiovascular disease, and chronic lung disease. It consists of two tablets, one is nirmatrelvir, which is designed to inhibit the SARS-CoV-2 protein to stop the virus from replicating; the other is ritonavir, which slows down nimaprevir to help it remain active in the body for longer at higher concentrations.
Tablets are solid preparations in the form of flakes or special-shaped flakes that are uniformly mixed with drugs and excipients. Because the ingredients contain starch and other excipients, it is easy to absorb moisture and cause fragmentation, deliquescence and adhesion, which affects the stability of the drug. Therefore, it is very important to protect these drugs from moisture on the packaging. The moisture-proof packaging of medicines has a desiccant inside the packaging, which can absorb the internal moisture and ensure the stability of drug storage, which is also the main reason why Paxlovid chooses moisture-proof packaging.
The above is the application of drug moisture-proof packaging in Pfizer's Paxlovid (Paxlovid) drugs. In addition, Merck's new crown oral drug Molnupiravir (Monupiravir) is a capsule dosage form, and it is also the selected moisture-proof packaging to better ensure the safety and stability of the drug within the validity period.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
